WALTHAM, Mass.--(BUSINESS WIRE)--BostonGene, a leading provider of artificial intelligence (AI)-driven molecular and immune profiling solutions, today announces it was named a Fierce Life Sciences Innovation Awards winner by Fierce Biotech and Fierce Pharma in the AI innovation category. The program showcases outstanding solutions that are driving improvements and transforming the industry. BostonGene's award-winning innovation addresses critical challenges in pathology. Traditional pathology r
BostonGene is a Massachusetts-based healthtech platform that offers solutions such as AI-based molecular profiling and analytics for physicians to treat patients with cancer.